Chemokine receptors form a major sub-family of G protein-coupled receptors (GPCRs) and they are 21 involved in a number of cellular and physiological processes related to our immune response and 22 regulation. A better structural understanding of ligand-binding, activation, signaling and regulation of 23 chemokine receptors is very important to design potentially therapeutic interventions for human 24 disorders arising from aberrant chemokine signaling. One of the key limitations in probing the structural 25 details of chemokine receptors is the availability of large amounts of purified, homogenous and fully 26 functional chemokine ligands, and the commercially available products, are not affordable for in-depth 27 structural studies. Moreover, production of uniformly isotope-labeled chemokines, for example, suitable 28 for NMR-based structural investigation, also remains challenging. Here, we have designed a streamlined 29 approach to express and purify the human chemokine CCL7 as well as its 15 N-, 15 N/ 13 C-, 2 H/ 15 N/ 13 C-30 isotope-labeled derivatives, at milligram levels using E. coli expression system. Purified CCL7 not only 31 maintains a well-folded three-dimensional structure as analyzed using circular dichroism and 1 H/ 15 N 32 NMR but it also induces coupling of heterotrimeric G-proteins and β-arrestins for selected chemokine 33 receptors in cellular system. Our strategy presented here may be applicable to other chemokines and 34 therefore, provide a potentially generic and cost-effective approach to produce chemokines in large 35 amounts for functional and structural studies. 36
Introduction 42
G protein-coupled receptors (GPCRs) are responsible for recognizing a broad range of ligands at the cell 43 surface and transmitting the signal across the membrane for downstream signaling and functional 44 response (Bockaert and Pin, 1999) . Considering their integral role in numerous pathophysiological 45 conditions, they are one of the most sought-after drug targets, and nearly one third of the currently 46 prescribed medicines exert their actions through this class of receptors (Kumari et al., 2015, Sriram and Insel, 2018). One of the major sub-families of GPCRs recognizes various chemokines in our body and 48 they are collectively grouped as chemokine receptors (Hughes and Nibbs, 2018, Griffith et al., 2014) . 49
These chemokine receptors are critically important for cellular migration among many other functions, 50 especially in the immune system (Griffith et al., 2014) . 51
Chemokines are small proteins with less than hundred amino acid residues and they typically 52 have overall conserved structural features (Turner et al., 2014 ). An interesting feature of chemokine 53 receptors is their ligand promiscuity where a given chemokine can interact with, and modulate several 54 related chemokine receptors (Proudfoot, 2002) . Investigating the interaction of chemokines with their 55 receptors in terms of precise ligand-receptor contacts, receptor activation, signaling and regulation is 56 important to understand how the receptor promiscuity and preferences are encoded. Unlike small 57 peptide GPCR ligands which can be chemically synthesized, chemokines typically harbor several 58 disulphide linkages and require proper cellular context for folding and attaining a functional 59 conformation. 60
Although several chemokines are commercially available, using them for structural studies that 61 require milligram amounts is not feasible. Moreover, batch-to-batch variation and lack of proper 62 functional characterization of these products further limit their usage in structural and functional 63 studies. A number of previous studies have documented the purification of chemokines from inclusion 64 bodies after recombinant expression in E. coli, however, their proper refolding and functionality remains 65 a concern. On the other hand, preparing large amounts of chemokines from baculovirus and mammalian 66 expression system may also not be cost-effective. Thus, new strategies to express and purify native 67 chemokines, preferably in soluble form without refolding step, is desirable to propel structure-function 68 studies of chemokine-chemokine receptor complexes. Moreover, streamlined methods to express and 69 purify isotope labeled chemokines for NMR-based structural characterization is also desirable. 70
Here, we have designed and optimized a streamlined protocol for expression and purification of 71 native (i.e. untagged) chemokine CCL7 in soluble form using E. coli. Our approach allowed us to also 72 produce sufficient amounts of isotope-labeled derivatives for structural studies using NMR. We 73 observed that native CCL7 purified from E. coli behaves as a full agonist for chemokine receptor CXCR2 74 and atypical chemokine receptor ACKR2a (also referred to as decoy D6 receptor; D6R) in G-protein 75 coupling and β-arrestin recruitment assays. The strategy described here should be applicable to other 76 chemokines and it should facilitate structural characterization of chemokine-chemokine receptor 77 complexes in future. 78
Results 79

Expression construct and purification of his6-tagged CCL7 80
We first designed an expression construct for his6-tagged CCL7 (referred to as his-CCL7 hereafter) in a 81 pGEMEX1 derived vector (Goncharuk et al., 2018) ( Figure 1A ) and optimized expression conditions by 82 systematic comparison of expression time, temperature and IPTG concentrations. We evaluated the 83 soluble expression of his-CCL7 using a previously published protocol (Goncharuk et al., 2011) and 84 identified that its expression is optimal when cultures are grown at 20°C for 48h after induction with 85 1mM IPTG in TB (Terrific Broth) medium. For growth in minimal salt medium, cells were grown at 27°C 86 for 48h after induction with 0.5mM IPTG induction to obtain maximal his-CCL7 expression. We followed 87 these conditions for expression scale-up and purified his-CCL7 using a two-step purification scheme 88 involving Ni-NTA agarose and cation-exchange chromatography. We obtained highly pure his-CCL7 with 89 an overall yield of about 25-30mg per liter culture ( Figure 1B) . In order to evaluate the conformational 90 homogeneity of purified his-CCL7, we analyzed the purified sample on Superdex 200 Increase (10/300 91 GL) based size exclusion chromatography which revealed a monodisperse elution profile ( Figure 1C ). The 92 purity and identity of his-CCL7 was further confirmed by LC-MS which displays a predominant peak at 93 m/z of 10,050.4 Da and confirms the formation of two disulphide bonds ( Figure 1D ). 94
NMR analysis of 15 N labeled his6-tagged CCL7 95
In order to test whether CCL7 purified using this protocol is properly folded, we confirmed its secondary 96 structure using CD spectroscopy and NMR spectroscopy (Figure 2A-B ). The observed secondary structure 97 in CD spectroscopy agrees well with the expected range for his-CCL7 ( Figure 2A ). For NMR spectroscopy, 98 we expressed and purified stable isotope labeled his-CCL7 by growing the cells in M9 minimal media 99 containing the corresponding source of stable isotopes. Subsequently, we used unlabeled (0.3mM) and 100 15 N-labeled (0.8 mM) his-CCL7 samples in H 2 O/D 2 O at pH 5.1 to acquire NMR data at 700MHz 101 spectrometer for structural verification and sequential NMR assignment ( Figure 2 ). We used non-102 uniform sampling technique (Kazimierczuk and Orekhov, 2015) to increase the resolution of 3-D 15 N-103 TOCSY-HSQC (20% fill of full time domain matrix) and 3-D 15 N-NOESY-HSQC experiment (38% fill of 104 matrix) resulting in reduction of experimental time to 24h and 58h, respectively. For assignment, we 105 adopted a previously reported entry for CCL7 (BMRB entry 4177) (Kim et al., 1996) as it does not have 106 any significant difference with our construct except the Gly-Ser sequence between his6 and CCL7 . We 107 observed that all the NMR NOESY contacts support well-known spatial structure of CCL7 published 108 previously in PDB, for example, by NMR (1BO0 and 1NCV, monomer and dimer, respectively) (Kim et al., 109 1996 , Meunier et al., 1997 and by X-ray crystallography (4ZKC) (Counago et al., 2015) . For example, the 110 α-helix K58-L67, and β-sheets L25-R30 and V41-T45, are clearly identified by their characteristic NOE 111 contacts (data not shown). Interestingly, we did not observe any of the eight inter-monomer NOE 112 contacts reported previously for CCL7 (Meunier et al., 1997) suggesting that his-CCL7 purified here is 113 primarily in a monomeric state. It is also plausible that our 15 N-resolved 3D experiments at high 114 resolution provide a more accurate analysis of ambiguous NOE restraints compared to earlier work using 115 2D NMR of unlabeled CCL7 (Meunier et al., 1997) . 116
Functional characterization of his-CCL7 in G-protein coupling assay 117
In order to probe the functionality of purified his-CCL7, we measured its ability to induce Gαi-coupling 118 upon stimulation of chemokine receptor CCR2 using GloSensor assay (Kumar et al., 2017) . We used 119 carboxyl-terminal Fc-tagged CCL7 (CCL7-Fc) purified from Sf9 cells as a reference. Although his-CCL7 120 behaved as a full-agonist at CCR2 with respect to Gαi-coupling with almost an equivalent B max as CCL7-Fc, 121 its potency was approximately 100 fold less than that of CCL7-Fc (IC 50 of ~10nM)( Figure 3A-B ).These 122 observations suggest that the his6-tag present at the N-terminus of CCL7 potentially interferes with its 123 ability to induce effective G-protein-coupling at CCR2. Thus, we designed an alternative strategy to 124 generate a native CCL7 without any N-terminal or C-terminal tag. 125
Expression construct and purification of native CCL7 126
In order to generate a fully native CCL7 without any modification at the N-or the C-terminal, we 127 designed an expression construct with N-terminal his6-tag followed by an enterokinase cleavage site 128 referred to as his-EK-CCL7 ( Figure 4A ). As enterokinase effectively cleaves the fusion protein after lysine 129 (or arginine), incorporation of its recognition sequence (Asp-Asp-Asp-Asp-Arg) before CCL7, allows the 130 generation of native N-terminus in CCL7. In order to enhance the availability of the enterokinase 131 cleavage site, a flexible linker (GSGSG) was engineered after the his6-tag. Similar to his6-tagged CCL7, 132 we optimized the expression conditions for his-EK-CCL7 and purified it first using Ni-NTA 133 chromatography ( Figure 4B ). Afterwards, we cleaved the fusion protein with the enterokinase which 134 yielded approximately 70% cleavage of the fusion protein. Subsequent cation exchange chromatography 135 using Resource S column efficiently separated the cleaved CCL7 and uncleaved fusion protein ( Figure  136 4B). In order to evaluate the conformational homogeneity of purified native CCL7, we analyzed the 137 purified sample on Superdex 200 Increase (10/300 GL) based size exclusion chromatography which 138 revealed a monodisperse elution profile ( Figure 4C ). 139
Functional characterization of native CCL7 in G-protein coupling and β-arrestin recruitment assays 140
We measured the functionality of purified native CCL7 using two different assays. First, we carried out 141
GloSensor assay as described above to evaluate the ability of native CCL7 to induce Gαi-coupling for 142 CCR2. Unlike his-CCL7, the native CCL7 was as potent and efficient as CCL7-Fc with an IC 50 of about 143 0.3nM ( Figure 5A-B ). These observations suggest that the his6-tag present at the N-terminus of CCL7 144 potentially interferes with its ability to induce effective G-protein-coupling at CCR2. Second, we carried 145 out confocal microscopy based assay to assess whether native CCL7 can effectively drive βarr 146 recruitment for two different 7TMRs namely the ACKR2 and CCR2. As presented in Figure 6A -D, we 147 observed efficient membrane translocation of βarr2 at early time-points (2-5 min) and subsequent 148 translocation to endosomes upon extended ligand stimulation (5-30 min), for both CCR2 and ACKR2. 149
These data demonstrate that native CCL7 purified from E. coli is functional in terms of inducing efficient 150 receptor-transducer coupling, and therefore, suitable for structure-function studies in future. 151
Discussion 152
Investigating the interaction of chemokines with chemokine receptors is an important subject area in 153 order to understand their activation, signaling and regulatory mechanisms. However, technical 154 challenges associated with preparing large amounts of chemokines in native and fully functional form 155 has limited our ability to study structural aspects of ligand-receptor complexes for the members of 156 chemokine receptor sub-family. Although some functional studies have used chemokines in E. coli, they 157 have primarily used constructs that do not yield native N-and C-terminus resulting in sub-optimal 158 affinity and efficacy, and making them less relevant for structural characterization. Furthermore, in most 159 cases, chemokines expressed in E. coli were present in inclusion bodies and had to be refolded for 160 subsequent studies; however, our protocol yielded soluble expression of CCL7 that can be purified in 161 milligram amounts without the need for any refolding procedure. In conclusion, we present a streamlined strategy for preparing milligram amounts of fully 181 functional CCL7 with native N-and C-terminus, which can potentially be adapted for other chemokines. 182
Our study paves the way for structural and functional characterization of CCL7-bound CCR2 and ACKR2, 183 and potentially other chemokine receptors. 
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Materials and methods 210
General reagents, strains and cell lines 211 XL-1 and BL21(DE3)pLysS strains of E.coli were purchased from Stratagene (USA) and a previously 212 described vector pGEMEX-1(his6) was used for generating expression constructs (Goncharuk et al., 213 2018) . Synthetic oligonucleotides were produced and DNA sequencing was performed by Evrogen 214 (Russia). Isotope labels ( 2 H, 15 N, 13 C) were incorporated using CIL reactives (United States). 215
Construction of the expression plasmids. 216
The human CCL7 gene was PCR amplified without the intrinsic signal sequence along with partial codon 217 optimization for expression in E. coli from the pFastBac-CCL7_Fc vector (designed and generated in 218 Afterwards, native CCL7 was isolated using two different and independent protocols. In the first 264 method, enterokinase cleaved sample was loaded on to Resource S cation exchange column followed by 265 elution using a linear gradient of NaCl (50-1000mM) over 10 column volumes. In the second method, 266 enterokinase cleaved sample was loaded onto 1mL Ni-NTA resin and flow through fractions containing 267 native CCL7 were collected. In both methods, fractions containing native CCL7 were pooled and stored 268 as described above. Expression and purification of CCL7-Fc construct using baculovirus infected Sf9 cells 269 will be described separately (Manuscript in preparation). 270
Size-exclusion chromatography 271
Purified his-CCL7 and native CCL7 were loaded on pre-equilibrated (20mM Hepes, 100mM NaCl, pH 7.5) 272
Superdex 200 Increase (10/300 GL) column (GE) in a volume of 100μl at 1-10mg/ml concentration. Uniformly Sampled mode (Kazimierczuk and Orekhov, 2015) . 282
GloSensor assay 283
The ability of purified CCL7 to trigger G-protein coupling was assessed with respect to inhibition of 284 forskolin-induced cAMP response using GloSensor assay as described previously ( then seeded in a 96 well plate at a density of 6 X 10 4 cells /100μl/ well. The plate was kept at 37:C for 290 90min in the CO 2 incubator followed by incubation at room temperature for 30 minutes. Basal reading 291 was read on luminescence mode of multi-plate reader (Victor X4). Since CCR2 is a Gαi-coupled receptor, 292 a receptor-independent adenylyl cyclase stimulator, Forskolin (10μM) was added to each well and 293 luminescence was recorded until reading were stable (10 cycle repeats). Thereafter, cells were 294 stimulated with varying doses of each ligand ranging from 0.01pM to 1μM and luminescence was 295 recorded for 60min using a microplate reader. Data was normalized with maximal response obtained 296 with highest ligand concentration after basal correction and analyzed using nonlinear regression in 297 GraphPad Prism software. Data presented in Figure 3 and 5 were measured simultaneously with shared 298 CCL7-Fc condition. 299
Confocal microscopy 300
In order to test the functionality of CCL7 in terms of βarr recruitment and trafficking, we used confocal 301 microscopy based analysis of βarr2 recruitment and trafficking as described previously (Ghosh et Circular dichroism (CD) spectrum of his-CCL7 acquired on J-810 spectropolarimeter (JASCO, Japan) at pH 5.8. The percentage of secondary structure elements were calculated in CONTINLL software (CDPro package) using SMP56 reference spectra. B. 1 H-15 N HSQC NMR spectrum of 15 N-labeled his-CCL7. Backbone NH groups are denoted by one-letter amino acid notation followed by the residue number. NMR signals of N-terminal his6-tag are not observed. Non-natural N-terminal GS-linker residues are denoted as G-1 and S0 and together with the visible NH group of Q1 that three signals constitute all differences with natural CCL7 in 1 H-15 N HSQC as described earlier in (Kim et.al. 1996) . The NMR signals of side-chain amines are prefixed by greek letters, two related resonances of NH 2 groups (N, Q) are linked by dotted lines. Signals of εR are folded in 15 N dimension (real 15 N chemical shift ~85 ppm). Central part of the spectrum is expanded for clarity. Chemical shifts of 1 H and 15 N are in ppm referenced to water resonance (4.7ppm). Conditions: Bruker Avance 700 MHz, 320 μL of 0.8 mM of His-CCL7 in H 2 O:D 2 O (9:1) pH 5.1, shigemi tube, temperature 30 o C. 
